Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local Level
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Real-World Evidence of SUL-DUR on Special Populations with CRAB Infection
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Optimizing Adult Vaccination Ecosystem in India
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines India
    Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator Therapy
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Addressing Healthcare Disparities in the Recognition, Early Diagnosis and Treatment of Primary Immunodeficiencies
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Knowledge Gaps in the Prevention of COVID-19 in Europe
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
    Hemophilia: Improving Knowledge of Novel Hemophilia Therapies Amongst Multidisciplinary Teams
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
    Release Date:
    Partner: Myovant Sciences
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Initiative to Improve the Treatment of Advanced or Metastatic Bladder Cancer Patients
    Release Date:
    Partner: NCCN, EMD Serono
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Educational Projects for Healthcare Professionals to Promote Cancer Patient Support
    Release Date:
    Partner: Japan Society of Clinical Oncology
    Review Process: Expert Review Panel
    Education Oncology Japan
    Latin America Needs Assessment of Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Menopause and Mental Health
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Efforts to Promote an Environmental Improvement for Cancer Genomic Medicine
    Release Date:
    Partner: Japan Society of Clinical Oncology
    Review Process: Expert Review Panel
    Education Oncology Japan
    Understanding of Biosimilars and Shared Decision Making including Financial Burden in Cancer Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Review and analysis of retrospective, local source, serotype distribution for invasive pneumococcal disease
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Addressing Diagnostic Challenges for Non-Alcoholic Steatohepatitis (NASH)
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All